Unit of Surgical Oncology, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy -
University of Modena and Reggio Emilia, Modena, Italy -
Minerva Urol Nephrol. 2022 Aug;74(4):400-408. doi: 10.23736/S2724-6051.21.04750-9. Epub 2021 Nov 18.
Colovesical fistulas (CVFs) account for approximately 95% enterovesical fistulas (EVFs). About 2/3 CVF cases are diverticular in origin. It mainly presents with urological signs such as pneumaturia and fecaluria. Diagnostic investigations aim at confirming the presence of a fistula. Although conservative management can be chosen for selected individuals, most patients are mainly treated through surgical interventions. CVF represents a challenging condition, which records high rates of morbidity and mortality. Our systematic review aimed at achieving deeper knowledge of both indications, in addition to short- and long-term outcomes related to CVF management.
We performed a systematic literature review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) guidelines. Pubmed/MEDLINE, Embase, Scopus, Cochrane Library and Web of Science databases were used to search all related literature.
The 22 included articles covered an approximately 37 years-study period (1982-2019), with a total 1365 patient population. CVF etiology was colonic diverticulitis in most cases (87.9%). Pneumaturia (50.1%), fecaluria (40.9%) and urinary tract infections (46.6%) were the most common symptoms. Abdomen computed tomography (CT) scan (80.5%), colonoscopy (74.5%) and cystoscopy (55.9%) were the most frequently performed diagnostic methods. Most CVF patients underwent surgery (97.1%) with open approach (63.3%). Almost all patients had colorectal resection with primary anastomosis with or without ostomy and 53.2% patients underwent primary repair or partial/total cystectomy. Four percent anastomotic leak, 1.8% bladder leak and 3.1% reoperations rates were identified. In an average 5-68-month follow-up, overall morbidity, overall mortality and recurrences rates recorded were 8-49%, 0-63% and 1.2%, respectively.
CVF mainly affects males and has diverticular origin in almost all cases. Pneumaturia, fecaluria and urinary tract infections are the most characteristic symptoms. Endoscopic tests and imaging are critical tools for diagnostic completion. Management of CVFs depends on the underlying disease. Surgical treatment represents the final approach and consists of resection and reanastomosis of offending intestinal segment, with or without bladder closure. In many cases, a single-stage surgical strategy is selected. Perioperative and long-term outcomes prove good.
结肠膀胱瘘(CVF)约占肠膀胱瘘(EVF)的 95%。约 2/3 的 CVF 病例源于憩室。它主要表现为尿气和粪尿等泌尿系统症状。诊断性检查旨在确认瘘管的存在。虽然可以选择对特定个体进行保守治疗,但大多数患者主要通过手术干预治疗。CVF 是一种具有挑战性的病症,其发病率和死亡率较高。我们的系统综述旨在更深入地了解 CVF 的治疗指征以及与 CVF 管理相关的短期和长期结果。
我们按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行了系统文献回顾。使用 Pubmed/MEDLINE、Embase、Scopus、Cochrane 图书馆和 Web of Science 数据库搜索所有相关文献。
22 篇纳入的文章涵盖了大约 37 年的研究期(1982-2019 年),共有 1365 名患者。大多数情况下,CVF 的病因是结肠憩室炎(87.9%)。最常见的症状是尿气(50.1%)、粪尿(40.9%)和尿路感染(46.6%)。腹部计算机断层扫描(CT)扫描(80.5%)、结肠镜检查(74.5%)和膀胱镜检查(55.9%)是最常进行的诊断方法。大多数 CVF 患者(97.1%)接受手术治疗,其中开放性手术(63.3%)。几乎所有患者均接受结直肠切除术和原发性吻合术,伴或不伴造口术,53.2%的患者接受原发性修复或部分/全膀胱切除术。吻合口漏的发生率为 4%,膀胱漏的发生率为 1.8%,再次手术的发生率为 3.1%。在平均 5-68 个月的随访中,总发病率、总死亡率和复发率分别为 8%-49%、0%-63%和 1.2%。
CVF 主要影响男性,几乎所有病例均源于憩室。尿气、粪尿和尿路感染是最典型的症状。内镜检查和影像学检查是完成诊断的关键工具。CVF 的治疗取决于基础疾病。手术治疗是最终的治疗方法,包括切除和吻合受影响的肠道段,伴或不伴膀胱闭合。在许多情况下,选择单一阶段的手术策略。围手术期和长期结果良好。